ScholarIQanswers from OpenAlex & ORCID
Tim Meyer
ResearcherPublications, citations & collaboration network
Tim Meyer is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Tim Meyer have?
ScholarIQindexed works
Tim Meyer has 521 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Tim Meyer have?
ScholarIQcitation count
Tim Meyer has 33,641 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Tim Meyer?
ScholarIQh-index
Tim Meyer has an h-index of 74 in OpenAlex.
What is the i10-index of Tim Meyer?
ScholarIQi10-index
Tim Meyer has an i10-index of 195 in OpenAlex.
What is the ORCID of Tim Meyer?
ScholarIQorcid
The ORCID for Tim Meyer is on the source record.
What is the OpenAlex record for Tim Meyer?
ScholarIQopenalex
The OpenAlex for Tim Meyer is on the source record.
What are the most-cited papers on Tim Meyer?
ScholarIQmost cited works
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
John Ramage, Alia Ahmed, J. Ardill, N.D.S. Bax, David J. Breen, Martyn Caplin, Pippa Corrie, Joseph Davar, Albert Davies, Valerie Lewington, Tim Meyer, John Newell‐Price, Graeme J. Poston, Nicholas S. Reed, Andrea Rockall, W P Steward, Rajesh V. Thakker, Christos Toubanakis, Juan W. Valle, Caroline S. Verbeke, Ashley Grossman
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
Bruno Sangro, Josepmaria Argemi, Maxime Ronot, Valérie Paradis, Tim Meyer, Vincenzo Mazzaferro, Peter Jepsen, Rita Golfieri, Peter R. Galle, Laura A. Dawson, María Reig
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
Josep M. Llovet, Masatoshi Kudo, Philippe Merle, Tim Meyer, Shukui Qin, Masafumi Ikeda, Ruocai Xu, Julien Edeline, Baek‐Yeol Ryoo, Zhenggang Ren, Gianluca Masi, Mariusz Kwiatkowski, Ho Yeong Lim, Jee Hyun Kim, В. В. Бредер, Hiromitsu Kumada, Ann‐Lii Cheng, Peter R. Galle, Shuichi Kaneko, Anran Wang, Kalgi Mody, Corina E. Dutcus, Leonid Dubrovsky, Abby B. Siegel, Richard S. Finn, Simone I. Strasser, Alexander Thompson, Aflah Roohullah, William Sievert, Vladimir Andelkovic, Jennifer J. Knox, Janine M. Davies, Jamil Asselah, Mayur Brahmania, Habeeb Majeed, Luis J. Villanueva-Rivera, Patricio Yañez Weber, Marcelo Garrido, Gonzalo Pizarro, Nicolás Yáñez, Ruocai Xu, Shuangyan Ou, Zhenggang Ren, Hongming Pan, Zhiqiang Meng, Kangsheng Gu, Xi Chen, Tao Zhang, Chunyi Hao, Peiguo Cao, Yabing Guo, Shukui Qin, Juxiang Xiao, Weijia Fang, Xin Wang, Yuxian Bai, Xiaoming Chen, Dong Yan, Hong Zhao, Jieer Ying, Carlos Bonilla, Olga Urrego, Ángela R. Zambrano, Mauricio Lema, Juan Carlos Restrepo, Andrés F. Cardona, Sandra Franco Millan, Madiedo Oscar, Víctor Ramos, Philippe Merle, Samuel Lesourd, Julien Edeline, Jean–Pierre Bronowicki, Marc Bourlière, Stéphane Cattan, Mohamed Bouattour, Laurent Mineur, Hélène Regnault, Barbara Dauvois, Kornelius Schulze, Gunnar Folprecht, Andreas Geier, Oliver Waidmann, Fabian Finkelmeier, Marino Venerito, Marie‐Luise Berres, Thomas Berg, Christian M. Lange, Hartmut Schmidt, Dirk Waldschmidt, Michael Bitzer, Ray McDermott, Austin G. Duffy, Gianluca Masi, Vittorina Zagonel, Giuseppe Tonini, Fabio Piscaglia, Stefania Gori, Mimma Rizzo, Elisa Biscaldi
Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor
Anna Karpathakis, Harpreet Dibra, Chistodoulos Pipinikas, Andrew Feber, Tiffany Morris, Joshua Francis, Dahmane Oukrif, Dalvinder Mandair, Marinos Pericleous, Mullan Mohmaduvesh, Stefano Serra, Olagunju Ogunbiyi, Marco Novelli, TuVinh Luong, L. Sylvia, Matthew H. Kulke, Christos Toumpanakis, Tim Meyer, Martyn Caplin, Matthew Meyerson, Stephan Beck, Christina Thirlwell